{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:18:48Z","timestamp":1772191128027,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,16]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Excess thyroid hormone is a well-documented risk factor for the development of atrial fibrillation (AF). The purpose of the study is to assess incidence of AF in patients taking levothyroxine for hypothyroidism and correlate it with biochemical thyroid function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>This was a retrospective cohort study of patients aged 18\u2009years and older who were treated with levothyroxine. Exclusion criteria were pre-existing diagnosis of AF and use of amiodarone in the prior year. Patients were followed 2012 through 2019 and stratified into 4 groups based on mean thyroid-stimulating hormone (TSH) value or mean fT4 value in 2012. Primary outcome was incidence of AF. Rates of AF between groups were assessed via Poisson regression with control of underlying confounders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 21,035 patients, 1091 (5.2%) developed AF during follow-up. Thyroid-stimulating hormone at baseline was not significantly associated with incident AF. Higher fT4 levels at baseline were associated with increased AF risk in age- and sex-adjusted analyses (hazard ratio 1.22; 95% CI, 1.03-1.44) for the highest quartile versus the lowest quartile of fT4.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In hypothyroid patients treated with levothyroxine, higher circulating fT4 levels are associated with increased risk of incident AF. There is no association of serum TSH with risk of AF. In patients at risk for AF, consideration should be given to avoiding fT4 levels in the highest quartile.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usae324","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T16:32:18Z","timestamp":1719246738000},"page":"e221-e227","source":"Crossref","is-referenced-by-count":1,"title":["Association of Serum Thyroxine and Atrial Fibrillation in Patients on Levothyroxine"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-6827","authenticated-orcid":false,"given":"Maria","family":"Kravchenko","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Brooke Army Medical Center and Wilford Hall Ambulatory Surgical Center , San Antonio, TX 78234,","place":["USA"]},{"name":"Maryland Metabolic Institute, Ascension Saint Agnes Hospital , Baltimore, MD 21229,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Forbes","sequence":"additional","affiliation":[{"name":"Defense Health Agency, Lackland Air Force Base , San Antonio, TX 78234,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-6754","authenticated-orcid":false,"given":"Sky","family":"Graybill","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Brooke Army Medical Center and Wilford Hall Ambulatory Surgical Center , San Antonio, TX 78234,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"8","key":"2025042508424642600_R1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"2025042508424642600_R2","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"key":"2025042508424642600_R3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/CIA.S23966","article-title":"Hypothyroidism in the elderly: diagnosis and management","volume":"7","author":"Bensenor","year":"2012","journal-title":"Clin Interv Aging"},{"issue":"10","key":"2025042508424642600_R4","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1001\/jamainternmed.2021.2686","article-title":"Levothyroxine use in the United States, 2008-2018","volume":"181","author":"Brito","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2025042508424642600_R5","article-title":"Medicine use and spending in the U.S.: a review of 2018 and outlook to 2023","volume-title":"Institute Report","author":"Institute TI","year":"2019"},{"issue":"1","key":"2025042508424642600_R6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025042508424642600_R7","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8130796","article-title":"Relationship between subclinical thyroid dysfunction and the risk of cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies","volume":"2017","author":"Sun","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"9","key":"2025042508424642600_R8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/archinte.167.9.928","article-title":"Association between serum free thyroxine concentration and atrial fibrillation","volume":"167","author":"Gammage","year":"2007","journal-title":"Arch Intern Med"},{"issue":"3","key":"2025042508424642600_R9","doi-asserted-by":"publisher","first-page":"E152","DOI":"10.25011\/cim.v35i3.16591","article-title":"Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer","volume":"35","author":"Abonowara","year":"2012","journal-title":"Clin Invest Med"},{"issue":"19","key":"2025042508424642600_R10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"issue":"22","key":"2025042508424642600_R11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"2025042508424642600_R12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF03343972","article-title":"Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations","volume":"25","author":"Woeber","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"2025042508424642600_R13","article-title":"A language and environment for statistical computing","volume-title":"R Foundation for Statistical Computing","author":"Team","year":"2022"},{"issue":"18","key":"2025042508424642600_R14","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"2025042508424642600_R15","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"issue":"15","key":"2025042508424642600_R16","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"issue":"1","key":"2025042508424642600_R17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy","volume":"95","author":"Flynn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025042508424642600_R18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"2025042508424642600_R19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","volume":"345","author":"Selmer","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"2025042508424642600_R20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/jce.14183","article-title":"Free thyroxine within the normal reference range predicts risk of atrial fibrillation","volume":"31","author":"Anderson","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"2025042508424642600_R21","doi-asserted-by":"publisher","first-page":"e3890","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025042508424642600_R22","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"issue":"12","key":"2025042508424642600_R23","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"2025042508424642600_R24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.149.3.526","article-title":"Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients","volume":"149","author":"de Los Santos","year":"1989","journal-title":"Arch Intern Med"},{"issue":"2","key":"2025042508424642600_R25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jcem-70-2-453","article-title":"Applications of a new chemiluminometric thyrotropin assay to subnormal measurement","volume":"70","author":"Spencer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025042508424642600_R26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196631","article-title":"Initial evaluation of thyroid dysfunction\u2014are simultaneous TSH and fT4 tests necessary?","volume":"13","author":"Schneider","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"2025042508424642600_R27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2265.1988.tb01219.x","article-title":"Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment","volume":"28","author":"Carr","year":"1988","journal-title":"Clin Endocrinol"},{"issue":"7","key":"2025042508424642600_R28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jama.299.7.769","article-title":"Triiodothyronine levels in athyreotic individuals during levothyroxine therapy","volume":"299","author":"Jonklaas","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"2025042508424642600_R29","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1089\/thy.2019.0535","article-title":"Clinical parameters are more likely to be associated with thyroid hormone levels than with thyrotropin levels: a systematic review and meta-analysis","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Thyroid"},{"issue":"6","key":"2025042508424642600_R30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-19-0006","article-title":"Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk","volume":"180","author":"Lillevang-Johansen","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025042508424642600_R31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.4158\/EP171761.RA","article-title":"Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks","volume":"23","author":"Samarasinghe","year":"2017","journal-title":"Endocr Pract"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/1-2\/e221\/58319019\/usae324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/1-2\/e221\/58319019\/usae324.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:42:53Z","timestamp":1745584973000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/1-2\/e221\/7697955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":31,"journal-issue":{"issue":"1-2","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2025,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usae324","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,6,24]]}}}